Evidence map›Paper›PMID 18489754›Full record

ArticleCell division2008

Insights from mouse models into human retinoblastoma.

David Macpherson

Abstract read
In one paragraph

Article in Cell division, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Cancers · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Looking for In Vitro Models for Retinal Diseases.International journal of molecular sciences · 2021
    Review
  7. TargetingCancers · 2021
    Review
  8. Article
  9. Article
  10. Transgenic Models in Retinoblastoma Research.Ocular oncology and pathology · 2015
    Review
  11. Article
  12. Article
  13. Animal models in retinoblastoma research.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society · 2013
    Article
  14. Article
  15. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.The Journal of clinical investigation · 2012
    Article
  16. Article
  17. Article
  18. Newly identified aspects of tumor suppression by RB.Disease models & mechanisms · 2011
    Review
  19. Article
  20. miR than meets the eye.Genes & development · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David MacphersonDepartment of Embryology, Carnegie Institution, Baltimore, MD, USA. macpherson@ciwemb.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel murine models of retinoblastoma based on Rb gene deletion in concert with inactivation of Rb family members have recently been developed. These new Rb knockout models of retinoblastoma provide excellent tools for pre-clinical studies and for the exploration of the genetics of tumorigenesis driven by RB inactivation. This review focuses on the developmental consequences of Rb deletion in the retina and the genetic interactions between Rb and the two other members of the pocket protein family, p107 (Rbl1) and p130 (Rbl2). There is increasing appreciation that homozygous RB mutations are insufficient for human retinoblastoma. Identifying and understanding secondary gene alterations that cooperate with RB inactivation in tumorigenesis may be facilitated by mouse models. Recent investigation of the p53 pathway in retinoblastoma, and evidence of spatial topology to early murine retinoblastoma are also discussed in this review.

Identifiers

PMID18489754
PMCPMC2430952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.